EPRX - Eupraxia Pharmaceuticals Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.98 -0.05 (-0.84%) --- --- --- --- -0.05 (-0.84%) --- ---

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Category: /stock/categories/na
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
45.45
VWAP:
5.94
RVol:
0.1509

Events

Period Kind Movement Occurred At

Related News